Kailera Therapeutics, Inc.

NASDAQ:KLRA

Biotechnology

Healthcare
$11.79 +2.66%

+$0.51 today

Market cap
$1.53B
Beta
0.00
52W Low $18.50High $28.23

Volume 0.42M

Average 0.80M

KLRA Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

No reported Gross Margin figures are available to summarize.

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How KLRA compares with its peers on the latest reported figures

KLRA Competitors Peer median
Gross Margin for KLRA and competitors
Company Period LTM level YoY 3-year change
VTVTvTv Therapeutics Inc.LTM Mar 2026100.0% +129.4 pp—
BIOABioAge Labs, Inc.LTM Mar 202699.4% -0.6 pp—
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 202692.1% -7.9 pp-0.3 pp
ORMPOramed Pharmaceuticals Inc.FY20250.7% —-99.4 pp
ALTAltimmune, Inc.LTM Mar 2026-41519.4% -41619.4 pp+0.0 pp
KLRAKailera Therapeutics, Inc.FY2025— ——
VKTXViking Therapeutics, Inc.FY2025— ——
MBXMBX Biosciences, Inc. Common StockFY2025— ——
BMEABiomea Fusion, Inc.FY2025— ——
GUTSFractyl Health, Inc. Common StockFY2025— ——
Peer median (excluding KLRA) 92.1%-4.2 pp-0.3 pp

Competitors are the stored peer set for KLRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kailera Therapeutics, Inc.

NASDAQ:KLRA

Intrinsic Alpha fair value

Locked

Current Price

$11.79

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.